PROTONIX IV Drug Patent Profile
✉ Email this page to a colleague
When do Protonix Iv patents expire, and what generic alternatives are available?
Protonix Iv is a drug marketed by Wyeth Pharms and is included in one NDA.
The generic ingredient in PROTONIX IV is pantoprazole sodium. There are forty-eight drug master file entries for this compound. Seventy-one suppliers are listed for this compound. Additional details are available on the pantoprazole sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Protonix Iv
A generic version of PROTONIX IV was approved as pantoprazole sodium by DR REDDYS LABS LTD on January 19th, 2011.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROTONIX IV?
- What are the global sales for PROTONIX IV?
- What is Average Wholesale Price for PROTONIX IV?
Summary for PROTONIX IV
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 94 |
Clinical Trials: | 32 |
Patent Applications: | 4,209 |
Drug Prices: | Drug price information for PROTONIX IV |
DailyMed Link: | PROTONIX IV at DailyMed |
Recent Clinical Trials for PROTONIX IV
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Pfizer | Phase 2 |
Mirati Therapeutics Inc. | Phase 1 |
Assiut University | Phase 2 |
Pharmacology for PROTONIX IV
Drug Class | Proton Pump Inhibitor |
Mechanism of Action | Proton Pump Inhibitors |
Paragraph IV (Patent) Challenges for PROTONIX IV
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
PROTONIX IV | For Injection | pantoprazole sodium | 40 mg/vial | 020988 | 1 | 2005-04-07 |
US Patents and Regulatory Information for PROTONIX IV
PROTONIX IV is protected by zero US patents and one FDA Regulatory Exclusivity.
FDA Regulatory Exclusivity protecting PROTONIX IV
NEW PATIENT POPULATION
Exclusivity Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wyeth Pharms | PROTONIX IV | pantoprazole sodium | INJECTABLE;INTRAVENOUS | 020988-001 | Mar 22, 2001 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PROTONIX IV
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Wyeth Pharms | PROTONIX IV | pantoprazole sodium | INJECTABLE;INTRAVENOUS | 020988-001 | Mar 22, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Wyeth Pharms | PROTONIX IV | pantoprazole sodium | INJECTABLE;INTRAVENOUS | 020988-001 | Mar 22, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Wyeth Pharms | PROTONIX IV | pantoprazole sodium | INJECTABLE;INTRAVENOUS | 020988-001 | Mar 22, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Wyeth Pharms | PROTONIX IV | pantoprazole sodium | INJECTABLE;INTRAVENOUS | 020988-001 | Mar 22, 2001 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PROTONIX IV
See the table below for patents covering PROTONIX IV around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
South Korea | 100910607 | ⤷ Sign Up | |
Israel | 155601 | PROCESS FOR PREPARING FREEZE-DRIED PANTOPRAZOLE AND LYOPHILIZED PANTOPRAZOLE PREPARATIONS PREPARED THEREBY | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 0241919 | ⤷ Sign Up | |
Germany | 19475025 | ⤷ Sign Up | |
Bulgaria | 107828 | ⤷ Sign Up | |
Singapore | 80192 | ⤷ Sign Up | |
European Patent Office | 1762249 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for PROTONIX IV
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0166287 | 96C0032 | Belgium | ⤷ Sign Up | PRODUCT NAME: PANTOPRAZOL. NATR. SESQUIHYDRAS PANTOPRAZOLE; NAT. REGISTRATION NO/DATE: 127 IS 98 F 3 19960222; FIRST REGISTRATION: SE 12131 19940506 |
0166287 | 96C0033 | Belgium | ⤷ Sign Up | PRODUCT NAME: EPTACOG ALFA (ACTIVATED); REGISTRATION NO/DATE: EU/1/96/006/002 19960223 |
0166287 | SPC/GB96/056 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: PANTOPRAZOLE AND ITS SALTS, HYDRATES AND HYDRATES OF ITS SALTS; REGISTERED: SE SE12131 19940506; UK 04889/0010 19960604 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |